Cerus (CERS) Depreciation & Amortization (CF) (2010 - 2026)
Cerus (CERS) posted Depreciation & Amortization (CF) of $461000.0 for Q2 2026, up 3.13% sequentially from $447000.0 in Q1 2026, and up 34.01% YoY from $344000.0 in Q2 2025.
Cerus (CERS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Cerus has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $461000.0 in Q2 2026.
- Quarterly Depreciation & Amortization (CF) rose 34.01% year-over-year to $461000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.7 million (up 20.65% YoY) and the FY2025 annual result came in at $1.4 million, down 23.13% from the prior year.
- Depreciation & Amortization (CF) improved to $461000.0 in Q2 2026 per CERS's latest filing, from $447000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $865000.0 in Q1 2022 and troughed at $307000.0 in Q1 2025.
- A 5-year average of $542888.9 and a median of $555500.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) sank 51.35% in 2025, then jumped 45.6% in 2026.
- Over 5 years, Depreciation & Amortization (CF) stood at $649000.0 in 2022, then fell by 0.31% to $647000.0 in 2023, then plunged by 48.69% to $332000.0 in 2024, then increased by 18.37% to $393000.0 in 2025, then grew by 17.3% to $461000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $461000.0, $447000.0, and $393000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 461,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 461,000.00 |
| Jun 30, 2026 | 461,000.00 |
| Mar 31, 2026 | 447,000.00 |
| Mar 31, 2026 | 447,000.00 |
| Dec 31, 2025 | 393,000.00 |
| Dec 31, 2025 | 393,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Jun 30, 2025 | 344,000.00 |
| Jun 30, 2025 | 344,000.00 |
| Mar 31, 2025 | 307,000.00 |
| Mar 31, 2025 | 307,000.00 |
| Dec 31, 2024 | 332,000.00 |
| Dec 31, 2024 | 332,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 480,000.00 |
| Mar 31, 2024 | 631,000.00 |
| Mar 31, 2024 | 631,000.00 |